Harmaline

Harmaline
Clinical data
Dependence; liability	N/A
Routes of; administration	Ingestion
Legal status
Legal status	AU: S9 (Prohibited substance); CA: Schedule III;
Identifiers
	IUPAC name 7-methoxy-1-methyl-4,9-dihydro-3H-pyrido[3,4-b]indole;
CAS Number	304-21-2 ;
PubChem CID	5280951;
ChemSpider	10211258 ;
UNII	CN58I4TOET;
KEGG	C06536 ;
ChEBI	CHEBI:28172 ;
ChEMBL	ChEMBL340807 ;
CompTox Dashboard (EPA)	DTXSID8041038 ;
ECHA InfoCard	100.005.594
Chemical and physical data
Formula	C13H14N2O
Molar mass	214.268 g·mol−1
3D model (JSmol)	Interactive image;
Melting point	232–234 °C (450–453 °F)
	SMILES COc3ccc2c1CCN=C(C)c1[nH]c2c3;
	InChI InChI=1S/C13H14N2O/c1-8-13-11(5-6-14-8)10-4-3-9(16-2)7-12(10)15-13/h3-4,7,15H,5-6H2,1-2H3 ; Key:RERZNCLIYCABFS-UHFFFAOYSA-N ;
	(what is this?) (verify)

Harmaline is a fluorescent indole alkaloid from the group of harmala alkaloids and beta-carbolines. It is the partly hydrogenated form of harmine.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.